Diagnosis can be a long, laborious journey, but novel technologies have the potential to drastically shorten that journey. The company RightEye has developed a test that uses eye tracking and infrared sensors to determine autism risk in children between the ages of 12 and 40 months in a matter of minutes. FACE2GENE, a test based on facial analysis and artificial intelligence technologies developed by digital health company FDNA, can recognize rare genetic disorders in seconds by analyzing a photo of a child’s face. Quicker diagnosis means earlier treatment, so these technologies aren’t just dazzling, they can make real differences in the lives of patients.